期刊文献+

二氟甲基鸟氨酸对K562细胞生长特性的影响及其与端粒酶活性的相关性 被引量:5

Effect of DFMO on the Growth of K562 Cells and Its Association with Telomerase Activity
下载PDF
导出
摘要 目的 :研究二氟甲基鸟氨酸 (DFMO)对K5 6 2细胞生长特性、调亡及端粒酶活性的影响。方法 :采用细胞计数、形态观察、FCM分析及DNA电泳分别检测DFMO处理的细胞生长速率、周期公布及细胞凋亡。按TRAP法对细胞端粒酶活性进行检测。结果 :DFMO处理的细胞生长速率明显减曼 ;G1期细胞增多而S期细胞减少 ;细胞表现凋亡诱导 ,且其端粒酶活性受到抑制。结论 :DFMO引起的K5 6 2细胞生长抑制及凋亡诱导与端粒酶活性抑制有关。端粒酶的失活是抑制多胺生物合成的抗癌分子机制重要事件之一。 Objective: To investigate the effects of DFMO on the growth characteristics,apoptosis and activity of telomerase of K562 cells.Methods:The growth rate,phase distribution of cell cycel and apoptosis of treated cells with DFMO were detected by cell cuout,morphological assay,FCM analysis and DNA electrophoresis,respectively.The telomerase activiety was examined by telomeric repeat amplification protocol(TRAP).Results: In K562 cells treated with DFMO,the growth rate was markedly retarded.The incrases in G 1-phase cells and decrease in s-phase population and induction of apoptosis were observed.The activity of telomerase of treated cells was inhibited.Conclusion: The growth inhibition and apoptosis induction of K562 cells treated by DFMO were associated with suppressed telomerase activity.It is suggested that inactivation of telomerase in cancer cells conld be one of important events in antitumor molecular mechanism of inhibition of polyamine biosynthesis.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2000年第4期247-250,共4页 Chinese Journal of Cancer Biotherapy
关键词 多胺 端粒酶 K562细胞 肿瘤 基因治疗 difluoromethylornithine (DFMO) polyamine K562 telomerase
  • 相关文献

参考文献2

二级参考文献3

共引文献10

同被引文献84

  • 1武进峰,兰晓煦.多胺生物合成抑制剂DFMO在泌尿系肿瘤研究中的应用及展望[J].国际泌尿系统杂志,2001,22(S1):153-155. 被引量:3
  • 2姚华,王慧明,吴求亮,范骏.茶多酚对舌鳞状细胞癌细胞增殖和端粒酶催化亚基的抑制作用[J].中华口腔医学杂志,2005,40(6):451-454. 被引量:8
  • 3商洪涛,刘锐,陈鹏,雷德林.平阳霉素对人口腔癌细胞的抑制作用和对端粒酶活性的影响[J].中国美容医学,2006,15(6):638-640. 被引量:3
  • 4[1]Kelland LR.Flavopiridol,the first cyclin-dependent kinase inhibitor to enter the clinic:current status.Expert Opin Investig Drugs,2000,9:2903-2911.
  • 5[2]Vlastos AT,West LA,Atkinson EN,et al.Results of a phase Ⅱ double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3.Clin Cancer Res,2005,11:390-396.
  • 6[4]Zou CP,Vlastos AT,Li Y,et al.Effects of difluoromethylornithine on growth inhibition and apoptosis in human cervical epithelial and cancerous cell lines.Gynecol Oncol,2002,85:266-273.
  • 7[6]Cheung TH,Yu MM,Lo KW,et al.Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix.Cancer Lett,2001,166:199-206.
  • 8[7]Clarke B,Chetty R.Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix.Gynecol Oncol,2001,82:238-246.
  • 9[9]Boiko IV,Mitchell M,Hu W.Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.Clin Cancer Res,1998,4:1383-1391.
  • 10[11]Wallick CJ,Gamper I,Thorne M,et al.Key role for p27Kip1,retinoblastoma protein Rb,and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.Oncogene,2005,24:5606-5618.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部